Jin-Liang Qi Selected Research

shikonin

5/2021	Progress on biosynthesis and function of the natural products of Zi Cao as a traditional Chinese medicinal herb.
1/2021	Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis.
1/2020	Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo.
1/2018	Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors.
12/2017	Identification of new shikonin derivatives as STAT3 inhibitors.
1/2017	Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Liang Qi Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 02/2013
2	Inflammation (Inflammations) 05/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2017
1	Ulcerative Colitis 01/2021
1	Cutaneous Malignant Melanoma 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018

Drug/Important Bio-Agent (IBA)

6	shikoninIBA 05/2021 - 01/2017
3	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2017 - 01/2016
2	Biological ProductsIBA 01/2020 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 03/2014
2	Pharmaceutical PreparationsIBA 01/2018 - 12/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2017 - 01/2017
2	Acetates (Acetic Acid Esters)FDA Link 01/2017 - 11/2014
2	EstersIBA 01/2017 - 01/2017
1	NaphthoquinonesIBA 05/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 01/2020
1	afimoxifene (hydroxytamoxifen)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Sincalide FDA Link 01/2020
1	Cadherins (E-Cadherin)IBA 01/2018
1	ovomacroglobulinIBA 01/2018
1	PMMB-187IBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	TubulinIBA 01/2017
1	PiperazineIBA 01/2017
1	norcantharidinIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 02/2013
1	Caspase 7IBA 02/2013
1	Caspase 9IBA 02/2013

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018
1	Transplantation 01/2018